License InteractSafe's interaction guides for your platform — without the clinical writing, pharmacist coordination, or source verification overhead. Available in multiple formats for publishers, clinics, apps, and brands.
All guides are reviewed by Sanford A. Orloff, RPh (ret), sourced from FDA, NIH, and peer-reviewed literature, and updated as new evidence emerges.
Our most-requested content. Covers semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), dulaglutide, and liraglutide in combination with cannabis, edibles, and related substances.
A comprehensive interaction database for cannabis with prescription and OTC medications — the question most drug databases don't answer well.
The citrus that blocks liver enzymes — covering how grapefruit affects statins, blood pressure medications, and 85+ other drugs. A perennial patient education need.
Preview on InteractSafe ↗Berberine, ashwagandha, and other popular supplements with real drug interaction profiles. Particularly relevant for platforms serving patients interested in natural health.
Drop-in HTML pages ready to publish on your site — styled or unstyled, your choice.
Iframe or JS embeds of specific guides for inline placement on product or topic pages.
Print-ready PDFs for clinic handouts, patient onboarding packets, and in-store materials.
Programmatic access to interaction data for apps and platforms. Enterprise tier. Inquire →
All plans include pharmacist-reviewed content and update notifications when source material changes.
One specific interaction guide for a targeted use case — GLP-1 + cannabis, cannabis + blood thinners, etc.
A curated bundle of related guides — e.g., all cannabis interactions, or all GLP-1 content.
Access to the complete InteractSafe interaction library, with API delivery and white-label rights.
All licensing is annual. Contact us for current pricing and custom configurations.